British patients up to 120 times more likely to suffer deadly reaction to Spain’s best-selling painkiller Nolotil, study reveals
The findings will come as no surprise to Olive Press readers after years of campaigning by this newspaper alongside Cristina Garcia del Campo.
Data presented at a recent congress of the Spanish Society of Hospital Pharmacy (SEFH) has highlighted safety concerns regarding metamizole, the active ingredient in the best-selling Spanish branded drug Nolotil. According to El Pais English, the drug is regularly prescribed for high fever and pain, but new data indicates potential risks that are especially concerning for UK citizens.
Euro Weekly News reports that while Nolotil is widely used in Spain for these purposes, the medication may be unfamiliar to people arriving from the UK. The outlet notes that metamizole is not authorised for use in the UK. El Pais English further notes that the molecule is also known as dipyrone and is referred to as “Mexican aspirin” in the United States, where it is banned.
Brief written by urgent.news from The Olive Press, Euro Weekly News, El Pais English — 3 reports on this story. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.